Literature DB >> 3907346

Use of the saline infusion test to diagnose the cause of primary aldosteronism.

E Arteaga, R Klein, E G Biglieri.   

Abstract

Angiotensin II has a major effect on mineralocorticoid hormone synthesis in patients with idiopathic hyperaldosteronism; it has little or no effect in those with an aldosterone-producing adenoma. To determine if this difference could be of use in clinically separating these two forms of primary aldosteronism, saline infusion tests were performed in 20 patients--14 with surgically proved aldosterone-producing adenoma and six with idiopathic hyperaldosteronism. With the patients receiving a balanced diet containing 120 meq of sodium, 1,250 ml of isotonic saline was infused intravenously between 8 A.M. and 10 A.M. after overnight recumbency. Plasma samples were obtained immediately before and after the infusion. Plasma cortisol level decreased appropriately in both groups, but plasma renin concentration decreased only in those patients with idiopathic hyperaldosteronism (p less than 0.05). Aldosterone and 18-hydroxycorticosterone levels decreased in both groups. To account for the circadian variation in adrenocorticotropin levels during the course of saline infusion, 18-hydroxycorticosterone/cortisol and aldosterone/cortisol ratios were examined. Both ratios increased in every patient with aldosterone-producing adenoma (p less than 0.01 and p less than 0.001, respectively), but these ratios remained unchanged or decreased in the patients with idiopathic hyperaldosteronism. This divergent variation in ratios after saline infusion allows for the differentiation of patients with an aldosterone-producing adenoma from those with idiopathic hyperaldosteronism. In patients with primary aldosteronism, an 18-hydroxycorticosterone/cortisol ratio of less than 3.0 or an aldosterone/cortisol ratio of less than 2.2 after saline infusion is diagnostic of idiopathic hyperaldosteronism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907346     DOI: 10.1016/0002-9343(85)90523-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Shortened saline infusion test for subtype prediction in primary aldosteronism.

Authors:  Kazutaka Nanba; Mika Tsuiki; Hironobu Umakoshi; Aya Nanba; Yuusuke Hirokawa; Takeshi Usui; Tetsuya Tagami; Akira Shimatsu; Tomoko Suzuki; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

2.  Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics.

Authors:  Kaoru Yamashita; Midori Yatabe; Yasufumi Seki; Kanako Bokuda; Daisuke Watanabe; Satoru Shimizu; Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-05-08       Impact factor: 3.872

3.  Surgical treatment of primary hyperaldosteronism.

Authors:  R J Weigel; S A Wells; J C Gunnells; G S Leight
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

4.  Minor Change of Plasma Renin Activity during the Saline Infusion Test Provide an Auxiliary Diagnostic Value for Primary Aldosteronism.

Authors:  Munire Adilijiang; Qin Luo; Menghui Wang; Delian Zhang; Xiaoguang Yao; Guoliang Wang; Keming Zhou; Nanfang Li
Journal:  Int J Endocrinol       Date:  2021-02-17       Impact factor: 3.257

5.  Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study.

Authors:  Helga Agusta Sigurjonsdottir; Mikael Gronowitz; Ove Andersson; Robert Eggertsen; Hans Herlitz; Augustinas Sakinis; Bo Wangberg; Gudmundur Johannsson
Journal:  BMC Endocr Disord       Date:  2012-09-08       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.